pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,972 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: recall×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06321198: A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

    Sponsor: Anhui Provincial Hospital. Phase: NA. Conditions: Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06264063: Study of Behavioral Dysfunctions and Related Neuronal Correlates in Patients With Dystonia

    Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: NA. Conditions: Dystonia, Neurologic Disorder, NEUROSCIENCE

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02799004: How Much Opioids Do You Need After Your Emergency Department Visit

    Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal. Phase: . Conditions: Acute Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07141004: A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

    Sponsor: Johnson & Johnson Private Limited. Phase: PHASE4. Conditions: Arthritis, Psoriatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07132684: Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE3. Conditions: AML, Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07466433: Apical Preparation Size in Regenerative Endodontics of Mature Teeth

    Sponsor: Marmara University. Phase: NA. Conditions: Apical Periodontitis, Mature Teeth, Regenerative Endodontic Treatment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07372352: Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

    Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Peripheral T Cells Lymphoma (PTCL)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06974149: Effects of Transcranial Direct Current Stimulation Associated With Neurofunctional Rehabilitation in Individuals With Spinocerebellar Ataxias

    Sponsor: Federal University of Health Science of Porto Alegre. Phase: NA. Conditions: Ataxias Espinocerebelares

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05751655: Observational Study of Drowning Patient's Emergency Care in Its Pre-hospital Phase.

    Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: . Conditions: Drowning

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07602855: A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Solid Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05500326: Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

    Sponsor: Murdoch Childrens Research Institute. Phase: PHASE2. Conditions: Scabies; Itch, Scabies

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04217278: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

    Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06258278: Clinical Results of Arthroscopic-Assisted Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears

    Sponsor: Gazi University. Phase: NA. Conditions: Massive Irreparable Rotator Cuff Tears

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07607678: A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Solid Cancer, Metastatic Solid Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05972343: COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

    Sponsor: Washington University School of Medicine. Phase: . Conditions: Breast Cancer, Cancer of the Breast

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02810743: Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer

    Sponsor: The Netherlands Cancer Institute. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07561515: Integrative Use of Sound Therapy for Mental Health Promotion

    Sponsor: Federal University of Minas Gerais. Phase: NA. Conditions: Sound Therapy, Music Therapy, Mental Health, Anxiety, Stress, Depression, Quality of Life, Acoustic Resonance, Insonia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07400315: First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Gastric or Gastroesophageal Junction Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07066215: Effects of Balance and Muscle Strength in Knee Osteoarthritis

    Sponsor: Bezmialem Vakif University. Phase: . Conditions: Primary Knee Osteoarthritis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07336615: A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals

    Sponsor: ClostraBio Inc.. Phase: NA. Conditions: Gastrointestinal, Overweight , Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07477015: Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Autoimmune Encephalitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06890078: Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Pneumocystis, Immunocompromised Patients

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05348785: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

    Sponsor: Biogen. Phase: PHASE2. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06344143: Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

    Sponsor: The Cleveland Clinic. Phase: . Conditions: Mild Autonomous Cortisol Secretion (MACS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07114315: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

    Sponsor: Akeso. Phase: PHASE2. Conditions: Pancreatic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05688215: Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03059485: DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

    Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE2. Conditions: Acute Myelogenous Leukemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06309485: Phase 2 Study of WGI-0301 for Advanced HCC

    Sponsor: Zhejiang Haichang Biotech Co., Ltd.. Phase: PHASE2. Conditions: Advanced Hepatocellular Carcinoma (HCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05849285: Evaluation of the Transitional and Lifelong Care Program

    Sponsor: Western University, Canada. Phase: . Conditions: Cerebral Palsy, Spina Bifida, Developmental Disability

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07501312: Remote Microphone Performance Comparison in Adults With Hearing Loss

    Sponsor: Sonova AG. Phase: NA. Conditions: Hearing Loss

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07423312: Lead Exposure and Multiple Sclerosis

    Sponsor: Assiut University. Phase: . Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07445828: Evaluation of Capsule Colonoscopy in Patients With Lynch Syndrome

    Sponsor: Region Skane. Phase: . Conditions: Lynch Syndrome

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07352228: Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices

    Sponsor: Xijing Hospital. Phase: PHASE4. Conditions: Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07429565: Testing APPA-1 in Healthy Subjects and Osteoarthritis Patients

    Sponsor: University of Liverpool. Phase: PHASE1. Conditions: Osteoarthritis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06731465: Efficiency, Efficacy, Periodontal & Occlusal Outcomes for Aligners Versus Fixed Orthodontic Appliances in Crowded Incisor Treatment

    Sponsor: University of Sharjah. Phase: NA. Conditions: Crowding of Anterior Mandibular Teeth

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03194165: Population Pharmacokinetics of Antiretroviral in Children

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00756665: Prostate Active Surveillance Study

    Sponsor: University of Washington. Phase: . Conditions: Prostatic Neoplasms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07500467: Upadacitinib for Refractory Takayasu Arteritis

    Sponsor: Liu Tian. Phase: . Conditions: Takayasu Arteritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04681807: Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

    Sponsor: The Royal Ottawa Mental Health Centre. Phase: NA. Conditions: Schizophrenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04993807: Data-driven SDM to Reduce Symptom Burden in AF

    Sponsor: Columbia University. Phase: NA. Conditions: Atrial Fibrillation, Patient Engagement

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06442592: Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

    Sponsor: Nantes University Hospital. Phase: NA. Conditions: Congenital Heart Defects, Neurodevelopmental Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06332092: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

    Sponsor: Fulgent Pharma LLC.. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07455136: A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

    Sponsor: Hoffmann-La Roche. Phase: . Conditions: Traumatic Brain Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06953336: Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Food Insecurity, Kidney Transplant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05361811: Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

    Sponsor: National Cancer Institute (NCI). Phase: NA. Conditions: Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07282171: A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

    Sponsor: Comanche Biopharma. Phase: PHASE1. Conditions: sFlt1 Mediated Preterm Preeclampsia, Preeclampsia, Preterm Preeclampsia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06738771: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

    Sponsor: Centre Hospitalier Régional d'Orléans. Phase: . Conditions: Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial, Antibacterial Agents, Beta-lactam Antibiotics

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04314544: Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

    Sponsor: Sun Pharmaceutical Industries Limited. Phase: PHASE3. Conditions: Active Psoriatic Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07195864: Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

    Sponsor: SIFI SpA. Phase: . Conditions: Acanthamoeba Keratitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05786664: Breast Cancer Survivorship Biorepository

    Sponsor: University of Southern California. Phase: . Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma

    full page →ctgov ↗
    ← prev
    page 49 of 100
    next →